Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy

Stem Cells and Development

Volumn 23, Issue 4, 2014, Pages 421-433

  Liu, Shih Ping ^a,b   Fu, Ru Huei ^a,b   Wu, Dong Chuan ^a,b   Hsu, Chien Yu ^b   Chang, Cheng Hsuan ^b   Lee, Wei ^a   Lee, Yu Da ^b   Liu, Chia Hui ^b   Chien, Ying Jiun ^b   Lin, Shinn Zong ^a,b,c   Shyu, Woei Cherng ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FEEDER CELL; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HYPOXIC CELL; KARYOTYPING; MOUSE; NERVE CELL; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPE; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; ONCOGENES; PLASMIDS; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS;

EID: 84893683220     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0182     Document Type: Article

References (37)

1. Ezashi T, P Das and RM Roberts. (2005). Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A 102:4783-4788.
2. Reubinoff BE, MF Pera, CY Fong, A Trounson and A Bongso. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404.
3. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
4. Clarke L and D van der Kooy. (2009). Low oxygen enhances primitive and definitive neural stem cell colony formation by inhibiting distinct cell death pathways. Stem Cells 27:1879-1886.
5. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
6. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
7. Huangfu D, K Osafune, R Maehr, W Guo, A Eijkelenboom, S Chen, W Muhlestein and DA Melton. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275.
8. Liu SP, RH Fu, YC Huang, SY Chen, YJ Chien, CY Hsu, CH Tsai, WC Shyu and SZ Lin. (2011). Induced pluripotent stem (iPS) cell research overview. Cell Transplant 20: 15-19.
9. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
10. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
11. Okita K, M Nakagawa, H Hyenjong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
12. Yoshida Y, K Takahashi, K Okita, T Ichisaka and S Yamanaka. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5:237-241.
13. Ding DC, WC Shyu, MF Chiang, SZ Lin, YC Chang, HJ Wang, CY Su and H Li. (2007). Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 27:339-353.
14. Liu SP, YS Li, YJ Chen, EP Chiang, AF Li, YH Lee, TF Tsai, M Hsiao, SF Huang and YM Chen. (2007). Glycine Nmethyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology 46:1413-1425.
15. Lee CM, SY Chen, YC Lee, CY Huang and YM Chen. (2006). Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway. Toxicol Appl Pharmacol 214:126-135.
16. Kawasaki H, K Mizuseki, S Nishikawa, S Kaneko, Y Kuwana, S Nakanishi, SI Nishikawa and Y Sasai. (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
17. Lee SH, N Lumelsky, L Studer, JM Auerbach and RD McKay. (2000). Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679.
18. Morrison SJ, PM White, C Zock and DJ Anderson. (1999). Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 96:737-749.
19. Mandai M, H Ikeda, ZB Jin, K Iseki, C Ishigami and M Takahashi. (2010). Use of lectins to enrich mouse ESderived retinal progenitor cells for the purpose of transplantation therapy. Cell Transplant 19:9-19.
20. Matsuda R, M Yoshikawa, H Kimura, Y Ouji, H Nakase, F Nishimura, J Nonaka, H Toriumi, S Yamada, et al. (2009). Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant 18:39-54.
21. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
22. Stadtfeld M, M Nagaya, J Utikal, G Weir and K Hochedlinger. (2008). Induced pluripotent stem cells generated without viral integration. Science 322:945-949.
23. Kim D, CH Kim, JI Moon, YG Chung, MY Chang, BS Han, S Ko, E Yang, KY Cha, R Lanza and KS Kim. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-476.
24. Woltjen K, IP Michael, P Mohseni, R Desai, M Mileikovsky, R Hamalainen, R Cowling, W Wang, P Liu, et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-770.
25. Lin SL, DC Chang, S Chang-Lin, CH Lin, DT Wu, DT Chen and SY Ying. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14:2115-2124.
26. Yu J, K Hu, K Smuga-Otto, S Tian, R Stewart, Slukvin, II and JA Thomson. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797-801.
27. Hong H, K Takahashi, T Ichisaka, T Aoi, O Kanagawa, M Nakagawa, K Okita and S Yamanaka. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132-1135.
28. Weinberg RA. (2007). The Biology of Cancer. Garland Science, New York.
29. Foja S, M Jung, B Harwardt, D Riemann, O Pelz-Ackermann and IS Schroeder. (2013). Hypoxia supports reprogramming of mesenchymal stromal cells via induction of embryonic stem cell-specific microRNA-302 cluster and pluripotency-associated genes. Cell Reprogram 15:68-79.
30. Lee SH, HN Suh, YJ Lee, BN Seo, JW Ha and HJ Han. (2012). Midkine prevented hypoxic injury of mouse embryonic stem cells through activation of Akt and HIF-1 alpha via low-density lipoprotein receptor-related protein-1. J Cell Physiol 227:1731-1739.
31. Seo BN, JM Ryu, SP Yun, JH Jeon, SS Park, KB Oh, JK Park and HJ Han. (2013). Delphinidin prevents hypoxiainduced mouse embryonic stem cell apoptosis through reduction of intracellular reactive oxygen species-mediated activation of JNK and NF-kappaB, and Akt inhibition. Apoptosis 18:811-824.
32. Okita K, Y Matsumura, Y Sato, A Okada, A Morizane, S Okamoto, H Hong, M Nakagawa, K Tanabe, et al. (2011). A more efficient method to generate integration-free human iPS cells. Nat Methods 8:409-412.
33. Yoshioka N, E Gros, HR Li, S Kumar, DC Deacon, C Maron, AR Muotri, NC Chi, XD Fu, BD Yu and SF Dowdy. (2013). Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA. Cell Stem Cell 13:246-254.
34. Jiang M, L Lv, H Ji, X Yang, W Zhu, L Cai, X Gu, C Chai, S Huang, J Sun and Q Dong. (2011). Induction of pluripotent stem cells transplantation therapy for ischemic stroke. Mol Cell Biochem 354:67-75.
35. Shyu WC, SZ Lin, MF Chiang, CY Su and H Li. (2006). Intracerebral peripheral blood stem cell (CD34 + ) implantation induces neuroplasticity by enhancing beta1 integrinmediated angiogenesis in chronic stroke rats. J Neurosci 26:3444-3453.
36. Shyu WC, CP Chen, SZ Lin, YJ Lee and H Li. (2007). Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke 38:367-374.
37. Shyu WC, DD Liu, SZ Lin, WW Li, CY Su, YC Chang, HJ Wang, HW Wang, CH Tsai and H Li. (2008). Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. J Clin Invest 118:2482-2495.